Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,598.08
-21.3525-1.32%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,618.99
Open:1,618.99
Low:1,555.04
Close:1,619.43
Volume:75.61M
Turnover:6.48B
Market Cap:1.66T
Float Cap:1.60T

Loading ...

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

TIPRANKS
·
Sep 26

Eli Lilly Gets Expanded Label Approval from FDA for Alopecia Drug

Dow Jones
·
Sep 26

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

THOMSON REUTERS
·
Sep 26

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26

Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

TIPRANKS
·
Sep 26

Pfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults

TIPRANKS
·
Sep 26

Top Midday Stories: Akamai's $11.6 Billion Anthropic Deal; Scholastic Q1 Loss Widens; Nektar Awarded $90 Million in Eli Lilly Case

MT Newswires Live
·
Sep 26

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live
·
Sep 25

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Deep News
·
Sep 25

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS
·
Sep 25

C4 Therapeutics Says Cemsidomide-Elranatamab Phase 1b Trial Clears 75 Μg Dose as Safe in Multiple Myeloma

Reuters
·
Sep 25

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Dow Jones
·
Sep 25

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

TIPRANKS
·
Sep 25

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live
·
Sep 25

Moderately bullish activity in Pfizer with shares up 0.9%

TIPRANKS
·
Sep 25

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

TIPRANKS
·
Sep 25